CA2450442A1 - Nouveau ligand et son adn - Google Patents

Nouveau ligand et son adn Download PDF

Info

Publication number
CA2450442A1
CA2450442A1 CA002450442A CA2450442A CA2450442A1 CA 2450442 A1 CA2450442 A1 CA 2450442A1 CA 002450442 A CA002450442 A CA 002450442A CA 2450442 A CA2450442 A CA 2450442A CA 2450442 A1 CA2450442 A1 CA 2450442A1
Authority
CA
Canada
Prior art keywords
seq
salt
amino acid
peptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002450442A
Other languages
English (en)
Inventor
Shuji Hinuma
Ryo Fujii
Shoji Fukusumi
Masaaki Mori
Hiromi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries, Ltd.
Shuji Hinuma
Ryo Fujii
Shoji Fukusumi
Masaaki Mori
Hiromi Yoshida
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd., Shuji Hinuma, Ryo Fujii, Shoji Fukusumi, Masaaki Mori, Hiromi Yoshida, Takeda Pharmaceutical Company Limited filed Critical Takeda Chemical Industries, Ltd.
Publication of CA2450442A1 publication Critical patent/CA2450442A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
CA002450442A 2001-06-14 2002-06-13 Nouveau ligand et son adn Abandoned CA2450442A1 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2001-180562 2001-06-14
JP2001180562 2001-06-14
JP2001216773 2001-07-17
JP2001-216773 2001-07-17
JP2001-359826 2001-11-26
JP2001359826 2001-11-26
JP2001401019 2001-12-28
JP2001-401019 2001-12-28
JP2002154533 2002-05-28
JP2002-154533 2002-05-28
PCT/JP2002/005915 WO2002102847A1 (fr) 2001-06-14 2002-06-13 Nouveau ligand et son adn

Publications (1)

Publication Number Publication Date
CA2450442A1 true CA2450442A1 (fr) 2002-12-27

Family

ID=27531924

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002450442A Abandoned CA2450442A1 (fr) 2001-06-14 2002-06-13 Nouveau ligand et son adn

Country Status (6)

Country Link
US (1) US7268212B2 (fr)
EP (1) EP1403281B1 (fr)
AT (1) ATE400584T1 (fr)
CA (1) CA2450442A1 (fr)
DE (1) DE60227519D1 (fr)
WO (1) WO2002102847A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057236A1 (fr) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel
AU2003221533A1 (en) * 2002-03-29 2003-10-13 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
WO2004080485A1 (fr) * 2003-03-13 2004-09-23 Takeda Pharmaceutical Company Substance preventive/therapeutique pour les maladies de l'appareil digestif superieur
JP4504098B2 (ja) * 2003-05-28 2010-07-14 武田薬品工業株式会社 抗体およびその用途
WO2004106382A1 (fr) * 2003-05-28 2004-12-09 Takeda Pharmaceutical Company Limited Anticorps et son utilisation
ITMI20041569A1 (it) * 2004-07-30 2004-10-30 Tecnogen Scpa "ligandi peptidici specifici per le immunoglobuline"
EP2162534B1 (fr) * 2007-05-24 2014-07-23 Apceth GmbH & Co. KG Cellules mésenchymales souches négatives pour le CD34 et génétiquement modifiées pour le traitement d'une tumeur
JP5378469B2 (ja) 2011-08-11 2013-12-25 学校法人 日本歯科大学 医療用薬剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591602A (en) * 1993-11-05 1997-01-07 O'dowd; Brian F. Nucleic acid encoding opioid receptor
CA2413195C (fr) * 2000-06-21 2012-01-17 Takeda Chemical Industries, Ltd. Ligand de gpr8 et son adn
EP1344823A4 (fr) * 2000-11-30 2005-03-16 Takeda Chemical Industries Ltd Nouvelles proteines du recepteur couple a la proteine g et leurs adn
EP1378749A4 (fr) 2001-04-12 2005-05-11 Takeda Pharmaceutical Procede de criblage
WO2002093161A1 (fr) 2001-05-15 2002-11-21 Takeda Chemical Industries, Ltd. Methode de balayage
WO2003057236A1 (fr) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel

Also Published As

Publication number Publication date
WO2002102847A1 (fr) 2002-12-27
EP1403281B1 (fr) 2008-07-09
EP1403281A1 (fr) 2004-03-31
ATE400584T1 (de) 2008-07-15
US20040220384A1 (en) 2004-11-04
US7268212B2 (en) 2007-09-11
DE60227519D1 (de) 2008-08-21
EP1403281A4 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
US7045299B2 (en) Physiologically active peptide and use thereof
EP1424392B1 (fr) Peptides-RF comme ligands pour récepteurs couplés aux protéines G
US7671174B2 (en) Ligand to GPR8
CA2387711A1 (fr) Proteine recepteur couplee a une proteine g et adn correspondant
EP1132405A1 (fr) Nouvelle proteine receptrice couplee a la proteine g, son adn et son ligand
US7268212B2 (en) Ligand of G protein-coupled receptor protein and DNA thereof
CA2592201C (fr) Neuromedine s et son utilisation
US7250272B2 (en) G protein-coupled receptor protein and DNA thereof
US7172876B2 (en) Method of screening therapeutic agents for nerve degeneration associated diseases
EP1344823A1 (fr) Nouvelles proteines du recepteur couple a la proteine g et leurs adn
US7323541B2 (en) Polypeptide DNA thereof and use of the same
US7943137B2 (en) FPRL1 ligands and use thereof
CA2395714A1 (fr) Polypeptides de type tachykinine et utilisation associee
EP1473303B1 (fr) Transporteur d'acide biliaire dépendant de sodium et son utilisation
JP4128030B2 (ja) 新規リガンドおよびそのｄｎａ
EP1428877A1 (fr) Nouvelle proteine et adn associe
JP4535670B2 (ja) 新規ポリペプチド、そのｄｎａおよびそれらの用途
US20040072293A1 (en) Novel physiologically active peptide and use thereof
EP1482038A1 (fr) Nouvelle proteine et adn de celle-ci
JP2004051622A (ja) 新規リガンドおよびそのｄｎａ

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued